Concepedia

Lee Tombs

LT

Statistics

Publications

24

Citations

698

H-Index

15

Active since

2012

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Research Triangle Park Foundation

University of Pennsylvania

Clinical Research Institute

Lee Tombs is an author at GlaxoSmithKline (United States) specializing in pharmacotherapy, pharmacology, and pulmonology.

Publications per year

2012–2024

24

Publications

24

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial

François Maltais, Leif Bjermer, Edward Kerwin et al. · Respiratory Research · 2019 · 125 citations · Full text

, , +17

Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study

Gregory Feldman, Ana R. Sousa, David A. Lipson et al. · Advances in Therapy · 2017 · 112 citations · Full text

, , +17

Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol

Dave Singh, M. Reza Maleki-Yazdi, Lee Tombs et al. · International Journal of COPD · 2016 · 69 citations · Full text

, , +17

Assessing Short-term Deterioration in Maintenance-naïve Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized Trials

M. Reza Maleki-Yazdi, Dave Singh, Antonio Anzueto et al. · Advances in Therapy · 2016 · 44 citations · Full text

, , +17

Long-term outcomes following first short-term clinically important deterioration in COPD

Ian Naya, Lee Tombs, Hana Muellerova et al. · Respiratory Research · 2018 · 41 citations · Full text

, , +17

1–5 of 24